LUT-014

N/A

Report date: 2024/02/29 15:22:34
NME

Base Information

Drug NameLUT-014
Drug Alias NameLUT-014C17071479-F
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsRadiodermatitisAcne Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLutris Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLutris Pharma Ltd
Inactive CompaniesN/A
Active IndicationsRadiodermatitis
Inactive IndicationsAcne Vulgaris

Other Information

ATC CodeN/A
Related LinksN/A